Biotech News

In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs.

CAMBRIDGE, Mass. & SEOUL, Korea, Dec. 17, 2013--Biogen Idec and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to commercialize anti-TNF biosimilar product candidates in Europe, including biosimilars for widely used therapies to treat conditions such as rheumatoid ... (more)

Doctors talking up drugs to other doctors has been quite lucrative for pharmaceutical companies - and the physicians who moonlight as their salesmen.

A federal judge on Tuesday rejected former SAC Capital Advisors LP portfolio manager Mathew Martoma's request to dismiss some insider trading charges because they were based on transactions not covered under U.S. securities laws.

Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

British drug company GlaxoSmithKline said Tuesday it is to scrap individual sales targets, just months after being hit by a bribery scandal allegedly conducted by its employees in China.

GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff - a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit.

The head of British drug maker GlaxoSmithKline told The New York Times on Monday that the company will stop paying doctors to promote its drugs.

Today, Siemens Healthcare Diagnostics Inc. announces that it has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

GlaxoSmithKline will stop paying doctors to promote its products, Chief Executive Andrew Witty said in an interview with the New York Times, in a move that could be a first for a major drug company.

Health Canada has approved a once-daily tablet for the treatment of chronic hepatitis C that could transform treatment of the disease for thousands of Canadians.

Cubist Pharmaceuticals Inc. shares jumped Monday after the drug company said that its latest trial for an antibiotic met its goal for treatment of complicated intra-abdominal infections.

The Centers for Disease Control and Prevention reports three people died over an eight-month period from 2012 to 2013 from heart complications due to Lyme disease.

Valeant Pharmaceuticals International, Inc. has a friendly deal to acquire Solta Medical, Inc. a California-based company that makes medical devices used in cosmetic surgery procedures.

Gregg Sando left a career in investment banking almost a decade ago to return as a 46-year- old to a student life filled with science lectures and pub outings.

GlaxoSmithKline Plc said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 percent from 50.7 percent through an open offer in a deal worth about 629 million pounds.

Product development, notably the introduction of the 2014 Chevrolet Corvette Stingray, and recruiting top talent to General Motors have been two of Mary Barra's top priorities in recent years.

As a local news organization, Patch covers stories of all kinds, from heartbreaking tragedies to inspiring tales of community brotherhood.

It is hard to believe that 43 years have passed since President Richard Nixon declared "War on Cancer".

In five short years, the women's health products company has leapfrogged from a startup prescription and over-the-counter vitamin vendor to a popular Wall Street-traded company, positioning itself to offer groundbreaking menopause treatments.